Risk factors

Omeros (OMER) risk factors

Item 1A of every Omeros Corp. 10-K on file, and what changed from one year to the next.

Open OMER in Gloomberb →
  • FY2025 10-K risk factors

    35 risks, 11 new, 3 dropped, 11 reworded since the prior year. Omeros achieved FDA approval for YARTEMLEA in December 2025, shifting its primary business focus to commercial execution.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    27 risks. Substantial doubt exists regarding the company's ability to continue as a going concern, driven by cumulative losses and high cash burn.

    Filed Mar 31, 2025